Statistical analyses
Anxiety, RBDSS, loss of consciousness, Parkinson's Disease Autonomic Function, stress disorder, Parkinson's Disease Rating Scale, Movement Disorder, RBD, arrhythmias/bundle branch block, SCOPA
MOVEMENT DISORDER, OTHER CARDIOVASCULAR DISEASE, PARKINSON'S DISEASE
Statistical analyses were performed with SPSS and GraphPad Prism v9, with alpha at 0.05. Data are presented as mean, standard deviation, number, and percentage of the whole. Data for the whole group (Tables Demographic characteristics.Data are presented as mean ± standard deviation, or raw frequency count with percent of the total number of available responses in parentheses.
RBD and other sleep characteristics.Data are presented as mean ± standard deviation, or raw frequency count with percent of the total number of available responses in parentheses. Other psychotropic/neurologic/sleep‐related medications use include zolpidem, trazodone, cannabidiol, lorazepam, prazosin, ropinirole, donepezil, pimavanserin, diphenhydramine, and gabapentin.RBDSS, RBD Severity Scale; SCOPA, Scales for Outcomes in Parkinson's Disease.
RBD characteristics and sleep outcomes based on antidepressant use.Data are presented as mean ± standard deviation, or raw frequency count with percent of the total number of available responses in parentheses. Data missing on SCOPA, Scales for Outcomes in Parkinson's Disease.
RBD characteristics and sleep outcomes in isolated RBD.Data are presented as mean ± standard deviation, or raw frequency count with percent of the total number of available responses in parentheses. See text for definition of isolated RBD. Other psychotropic/neurologic/sleep‐related medications use include zolpidem, trazodone, cannabidiol, lorazepam, prazosin, ropinirole, donepezil, pimavanserin, diphenhydramine, and gabapentin.SCOPA, Scales for Outcomes in Parkinson's Disease.
General, cardio/cerebrovascular, neurological, and mental health history.Data are presented as mean ± standard deviation, or raw frequency count with percent of the total number of available responses in parentheses. Other cardiovascular disease includes, arrhythmias/bundle branch block (BAI, Beck Anxiety Inventory; BP, blood pressure; LOC, loss of consciousness; PCL‐5, post‐traumatic stress disorder checklist for DSM‐V; PHQ‐9, Patient Health Questionnaire‐9; SCOPA‐AUT, scales for Outcomes in Parkinson's Disease Autonomic Function.
Cognition, motor, autonomic, and sensory function.Data are presented as mean ± standard deviation, or raw frequency count with percent of the total number of available responses in parentheses. Criteria for abnormality: Montreal Cognitive Assessment, Z‐score at or below 1.5 SD based on total score ≤ 25; MDS‐UPDRS part 3, based on total score > 4; Purdue Pegboard, based on total score < 9; Alternate Tap Test, based on total score < 165; Timed Up and Go, based on total time ≥ 13.5 s; Farnsworth‐Munsell Color Vision Test, based on total score > 100; Brief Smell Identification Test, based on total score ≤ 8.BP, blood pressure; MDS‐UPDRS, Movement Disorder Society Unified Parkinson's Disease Rating Scale.
